Drug Trial Radar · NCT06445946
DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Treatment of Gestational Diabetes
Last checked: Nov 19, 2026Latest source record: Oct 7, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
1,572
Planned (sponsor's estimate)
Start
Aug 1, 2024
Primary completion
Dec 2029
Study completion Dec 2030
Sponsor
- Lead sponsor
- Ohio State UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Patient-Centered Outcomes Research Institute; The George Washington University Biostatistics Center
- First posted
- Jun 6, 2024
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- Female only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a non-inferiority patient-centered and pragmatic comparative-effectiveness pregnancy randomized controlled trial (RCT) with postpartum maternal and child follow-up through 2 years of 1,572 individuals with gestational diabetes mellitus (GDM) randomized to oral metformin versus injectable insulin. This study will determine if metformin is not inferior to insulin in reducing adverse pregnancy outcomes, is comparably safe for exposed individuals and children, and if patient-reported factors, including facilitators of and barriers to use, differ between metformin and insulin. A total of 1,572 pregnant individuals with GDM who need pharmacotherapy will be recruited at 20 U.S. sites using consistent treatment criteria to metformin versus insulin. Participants and their children will be followed through delivery to two years postpartum.
Conditions
- Gestational Diabetes Mellitus
- Pregnancy, High Risk
Interventions
MetforminDrug
Individuals randomized to this arm will receive oral metformin tablets for their Gestational diabetes mellitus treatment.
InsulinDrug
Individuals randomized to this arm will receive injectable insulin for their Gestational diabetes mellitus treatment.
Primary outcomes
What the sponsor says the trial is designed to measure.
- A neonatal composite adverse outcome of large-for-gestational-age (LGA) birthweight, hypoglycemia, hyperbilirubinemia, and/or death.Time frame: LGA at birth. Hypoglycemia <24 hours after birth. Hyperbilirubinemia within the first week after birth. Death between randomization to hospital discharge or 30 days postnatal.
- Child body mass index (BMI) at 2 years of ageTime frame: 2 years of age.
Locations
26 sites in 1 country. Site status is shown where the registry gives one.
University of Alabama
Tuscaloosa, Alabama · Recruiting
Cedars Sinai Medical Center
Los Angeles, California · Recruiting
University of California San Francisco
San Francisco, California · Recruiting
Yale School of Medicine
New Haven, Connecticut · Recruiting
Christiana Care
Newark, Delaware · Withdrawn
University of South Florida
Tampa, Florida · Recruiting
Tufts University
Boston, Massachusetts · Recruiting
Massachusetts General Hospital
Boston, Massachusetts · Recruiting
Beth Israel Deaconess Medical Center
Boston, Massachusetts · Terminated
Washington University in St. Louis
St Louis, Missouri · Recruiting
University of New Mexico
Albuquerque, New Mexico · Recruiting
Columbia University Irving Medical Center
New York, New York · Recruiting
University of North Caroline
Chapel Hill, North Carolina · Withdrawn
Wake Forest University
Winston-Salem, North Carolina · Recruiting
The Ohio State University Wexner Medical Center OB/GYN Maternal and Fetal Medicine
Columbus, Ohio · Recruiting
Premier Health - Miami Valley Hospital
Dayton, Ohio · Recruiting
Kettering Health
Kettering, Ohio · Not yet recruiting
University of Pennsylvania
Philadelphia, Pennsylvania · Recruiting
University of Pittsburgh
Pittsburgh, Pennsylvania · Recruiting
Brown University
Providence, Rhode Island · Recruiting
University of South Carolina Greenville
Greenville, South Carolina · Recruiting
University of Texas Austin
Austin, Texas · Recruiting
Austin Maternal Fetal Medicine
Austin, Texas · Recruiting
University of Texas Health Science Center
Houston, Texas · Recruiting
Eastern Virginia Medical School - Old Dominion University
Norfolk, Virginia · Recruiting
Medical College of Wisconsin
Milwaukee, Wisconsin · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.